The trademark application Primrose was filed by Ceres Pharma, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on April 24, 2023, and it was registered by office on August 1, 2023 without any oppositions.
The application was filed in Dutch (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on April 29, 2024.
The Refusal with reference B 018699890 was partially rejected according to Article 7(1)(b) EUTMR with decision issued on December 18, 2022 by the EUIPO.